Hair loss over entire body. Looking for the positives it makes bathing and hair styles simple!
Ulcer break outs in the mouth and throat. Biotene and Magic mouthwash along with treatment for yeast infections.
Extreme fatigue after three treatments. Just continue a walking regiment at a slower pace.
Permanent numbness in fingers and toes. I don’t try to pick up flat objects like paper clips, change, etc. I just wipe them off the desk in my hand and I wear flatter shoes for safety.
- You are viewing a Navigating Care library resource.
- Go to Library

Regimen Information
For Parapatin + Taxotere, including Side Effects
Parapatin + Taxotere
Drugs in this Regimen:
How Parapatin + Taxotere chemotherapy is given and possible side effects.
Parapatin + Taxotere for the treatment of Ovarian Cancer
Paraplatin + Taxotere is a chemotherapy regimen used in the treatment of ovarian cancer. This treatment involves two chemotherapy drugs: Paraplatin (carboplatin) and Taxotere (docetaxel).
Chemotherapy is often given as a combination of drugs. Combinations usually work better than single drugs because different drugs kill cancer cells in different ways.
MOST COMMON SIDE EFFECTS OF PARAPLATIN + TAXOTERE
-
Nausea & Vomiting
-
Hair Loss
-
Risk of Infection
-
Diarrhea
For more information, see the 'Expert Resources' tab below.
Community Responses
Often, the most helpful information regarding treatment side effects comes not from clinical brochures, but rather from other patients like you. We've collected the most helpful community resources to help you prepare for the side effects and coping tips for your chemotherapy regimen.
What side effects did you experience while on this medication?
This discussion needs your voice!
What were the specific side effects that you experienced while taking this medication? How did you manage them?
What coping tips would you give to new patients on this regimen?
This discussion needs your voice!
What do you wish you had known before taking this medication? What information would you like to pass on to patients who are beginning this medication?